Helius Medical Technologies, Inc. announced that it has received a letter of intent (LOI) from the Québec Ministry of Health and Social Services (MSSS) for the purchase of 30 Portable Neuromodulation Stimulator (PoNS®) devices as part of an initiative to assess the value of using PoNS to treat patients suffering symptoms due to stroke. The sales of these PoNS devices are expected to commence in the fourth quarter of 2023 and extend through the first quarter of 2024.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.15 USD | -7.78% | -19.21% | -49.00% |
Apr. 24 | Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center | CI |
Apr. 03 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.00% | 3.99M | |
+8.56% | 219B | |
+7.09% | 183B | |
+11.03% | 133B | |
+25.32% | 108B | |
+0.27% | 63.06B | |
+12.97% | 52.02B | |
+3.96% | 48.2B | |
+0.28% | 40.37B | |
+13.63% | 39.35B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Receives Letter of Intent from Québec Ministry of Health and Social Services to Purchase 30 PoNS Devices